EGFR and cancer: Furthermore, cancer cell-derived EVs containing oncogenic EGFR were able to transfer this receptor to primary endothelial cells in vitro and in vivo, resulting in the onset of autocrine VEGF production and phosphorylation of VEGFR2 [118].